April 16, 2010

The Harvard study,  published in the Journal of the American Medical Association, evaluated 827 suicidal acts (801

Read More
Specific Anticonvulsants Increase Suicide Risk

April 8, 2010

New York Times columnist, David Leonhardt, applauds the new Medicare policy inaugurating comparative risk/ benefit analyses of

Read More
In Medicine, the Power of No vs. Psychiatry’s Mass Overtreatment

April 3, 2010

Dr. Stephen Murgatroyd notes that psychiatry’s diagnostic bible, the DSM, is "By no stretch of the imagination

Read More
An Educator Asks: Is Psychiatry a Disorder in Need of Treatment?

March 30, 2010

Over the years, as he witnessed the wholesale practice of sedating young children with powerful toxic, psychotropic

Read More
Parity Likely to Increase Wholesale Sedation of Children

March 23, 2010

Following the acknowledgement reported by The New York Times (Feb. 10, 2010), that "Studies of teenagers identified

Read More
“Psychosis Risk Syndrome”– Psychiatry’s Hunting License

February 25, 2010

The publication of “We’ve Got Issues,” a book of stories by Judith Warner, a regular New York

Read More
Judith Warner misses the real questions about medicating children

February 22, 2010

While it came as no surprise that Rebecca Riley’s mother was convicted of murder, most observers–including, it

Read More
Rebecca Riley’s Murderous Care Remembered

February 10, 2010

A report in the New York Times "Revising Book on Disorders of the Mind" by Benedict Carey

Read More
DSM5 Revisions

December 11, 2009

A front page article in The New York Times raises the long-overdue alarms about the forced drugging

Read More
America’s Poor Children Likelier to Get Antipsychotics_NYT

September 3, 2009

The level of corruption that the pharmaceutical industry engages in–with assistance by prominent academic physicians who prostitute

Read More
Pfizer’s $2.3 Billion Settlement Leaves Victims in the lurch

September 1, 2009

Pharmaceutical companies are in business to sell their drugs at prices that will yield the highest profit.

Read More
Ghostwritten reports corrupt science, undermine public health

August 18, 2009

Dr. Daniel Schultz, who has been FDA’s chief medical device official, is the first high ranking FDA

Read More
Top FDA Officials, Compromised by Conflicts of Interest

August 16, 2009

The FDA has approved Schering Plough’s new antipsychotic, asenapine (Saphris), for the treatment of schizophrenia and mania

Read More
FDA Approves Another Dangerous Antipsychotic, Asenapine

June 18, 2009

A study that attempted to replicate the “seminal” study that laid the foundation for psychiatry’s “serotonin theory”

Read More
Gene Theory for Depression Is Now Discredited